Recombinant lipid-tagged antibody fragments as functional cell-surface receptors

This publication has 25 references indexed in Scilit:

• An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules
  Cancer Gene Therapy, 1999
• Genetically modified tumour vaccines – where we are today
  Cancer Treatment Reviews, 1999
• Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
  The Lancet, 1999
• Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus
  Gene Therapy, 1999
• Biosynthetically lipid‐modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes
  FEBS Letters, 1996
• F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes.
  Journal of Clinical Investigation, 1996
• Selection and Application of Human Single Chain Fv Antibody Fragments from a Semi-synthetic Phage Antibody Display Library with Designed CDR3 Regions
  Journal of Molecular Biology, 1995
• Functional Immunoliposomes Harboring a Biosynthetically Lipid-Tagged Single-Chain Antibody
  Biochemistry, 1994
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion Surface
  Science, 1985